Inventor · disambiguated record
David A. Paisner
Also filed as: PAISNER DAVID · PAISNER DAVID A · PAISNER DAVID ABRAHAM
12 granted patents·5 pending applications·121 citations·filing 2007–2022
92Inventor score
Top patents by PatentIndex Score
17 records- 0196US9701643B2Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2015·Granted Jul 11, 2017·19 cites·18 claims
- 0294US10040770B2Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2017·Granted Aug 7, 2018·7 cites·18 claims
- 0394US9139534B2Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewithBENNETT BRYDON L·Filed 2012·Granted Sep 22, 2015·30 cites·76 claims
- 0493US10266500B2Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2018·Granted Apr 23, 2019·5 cites·14 claims
- 0592US11325890B2Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2020·Granted May 10, 2022·2 cites·18 claims
- 0692US8242154B2Compounds, compositions and methods of using same for modulating uric acid levelsGUNIC ESMIR·Filed 2009·Granted Aug 14, 2012·11 cites·13 claims
- 0790US8633232B2Compounds, compositions and methods of using same for modulating uric acid levelsGUNIC ESMIR·Filed 2012·Granted Jan 21, 2014·7 cites·13 claims
- 0890US8193234B2Compounds, compositions and methods of using same for modulating uric acid levelsGUNIC ESMIR·Filed 2009·Granted Jun 5, 2012·13 cites·37 claims
- 0990US8173690B2Compounds, compositions and methods of using same for modulating uric acid levelsGUNIC ESMIR·Filed 2009·Granted May 8, 2012·21 cites·37 claims
- 1086US10919865B2Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2019·Granted Feb 16, 2021·3 cites·16 claims
- 1180US12129237B2Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2022·Granted Oct 29, 2024·0 cites·6 claims
- 1280US8344012B2Compounds, compositions and methods of using same for modulating uric acid levelsARDEA BIOSCIENCES INC·Filed 2009·Granted Jan 1, 2013·3 cites·13 claims
- 1359US2014128338A1Compounds, compositions and methods of using same for modulating uric acid levelsARDEA BIOSCIENCES INC·Filed 2013·Application pending·0 cites
- 1458US2016221969A1Compounds, compositions and methods of using same for modulating uric acid levelsARDEA BIOSCIENCES INC·Filed 2015·Application pending·0 cites
- 1558US2024228462A1Crystalline forms of n-{3-[(1s)-1-{[6-(3,4-dimethoxyphenyl)pyrazin-2- yl]amino}ethyl]phenyl}-5-methylpyridine-3-carboxamide and related products and methodsGB002 INC·Filed 2022·Application pending·0 cites
- 1654US2013040963A1Compounds, Compositions and Methods of Using Same for Modulating Uric Acid LevelsARDEA BIOSCIENCES INC·Filed 2012·Application pending·0 cites
- 1750US2008045534A1Derivatives of 1,3-diamino benzene as potassium channel modulatorsVALEANT PHARMACEUTICALS NORTH·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David A. Paisner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →